Celyad SA (CYAD) vs Radiopharm Theranostics Limited - Sponsored ADR (RADX)

Celyad SA and Radiopharm Theranostics Limited - Sponsored ADR are both Biotechnology companies. Celyad SA and Radiopharm Theranostics Limited - Sponsored ADR are of similar size ($24.7M and $23.8M). Across the 5 metrics below, Celyad SA leads on 3 and Radiopharm Theranostics Limited - Sponsored ADR on 2.

Valuation

Metric CYAD RADX Biotechnology median
P/E n/m — 7.88
P/S n/m — 11.47
P/B 11.18 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (708.87%) — (28.84%)
Free cash flow yield (438.06%) 0.00% (23.03%)

Profitability

Metric CYAD RADX Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin — — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (57.72%)
Return on assets 0.00% 0.00% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CYAD RADX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 113.33% (1.97%) —
Revenue growth, 5-year CAGR (63.51%) — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CYAD RADX Biotechnology median
Debt to equity (0.24) 0.00 0.00
Current ratio 0.66 1.16 4.73
Net debt to EBITDA (1.62) 0.07 0.96

Dividend

Metric CYAD RADX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric CYAD RADX Biotechnology median
Market cap 23.79m 24.68m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack